Note to our followers: Due to a lack of sufficient funding, HealthNewsReview.org will cease daily publication of new content at the end of 2018. Publisher Gary Schwitzer and other contributors may post new articles periodically. If you wish to donate, your gift might help keep the site available to the public for a few more years, by defraying costs of web hosting and maintenance. All of our 6,000+ published articles contain lessons to help people improve their critical thinking about health care. Read more about our change in status. And here's how to make a donation.

Do you write news releases? And want help?
We offer free pre-publication review of releases. SEE MORE →

October 16, 2018 | Story Review

Inquirer’s look at using Facebook to screen for depression emphasizes research ‘is still in very early stages’

It would have been helpful if the story had explored who would pay for this kind of screening, and what we know about depression screening in general: Is it effective?

4 Star

Depression often goes undiagnosed. Researchers are turning to Facebook to change that.

October 15, 2018 | News Release Review

Serious potential harms and financial conflicts missing in recap of study on vaginal laser surgery for menopausal symptoms

The release fails to mention that the FDA has issued a warning against the use of vaginal laser surgery for menopausal symptoms.

2 Star

Getting relief from sexual dysfunction and incontinence caused by menopause

October 12, 2018 | Story Review

Reuters once again rehashes drug company news release

There was also no information about how or where these research findings were presented, nor was there any input from independent experts.

2 Star

J&J's Stelara succeeds in chronic bowel disease study

October 11, 2018 | Story Review

Doctor’s $620,000 conflict of interest not disclosed in Inquirer story on new migraine drugs

But it was good to see how the story included the prices of the drugs and mentioned the lack of long-term safety data.

3 Star

Migraine patients can now try three new drugs for prevention

October 11, 2018 | News Release Review

More unwarranted hype over the unique benefits of proton therapy, this time in combo with thermal therapy

The University of Maryland Medical Center is the latest to make an evidence-free claim that its proton beam treatment beats other types of cancer therapies.

1 Star

High-Precision Proton Therapy More Effective in Treating Certain Cancers When Combined with Thermal Therapy

October 10, 2018 | News Release Review

Caveats and outside expert balance speculative claim that ‘anti-inflammatory’ diet might benefit bipolar disorder patients

The release includes cautions and an outside perspective — something we’d like to see more of in health care PR announcements.

3 Star

Study shows diet and weight may affect response to bipolar disorder treatment

October 9, 2018 | News Release Review

Plug for study of midwifery for low income women is fuzzy on benefits, costs

But the study could pave the way for further studies that establish midwifery’s benefits and risks.

3 Star

Midwifery linked to lower odds of birth complications for low-income women

October 8, 2018 | Story Review

AP offers strong reporting about the evidence for a drug treatment for moderate bone loss

This story did a good job of explaining the findings and the quality of evidence.

5 Star

Study suggests more older women may benefit from bone drugs

Toolkit

Tips & Resources for Analyzing Health Care Claims

View More

Toolkit

Story Reviews

Our team of reviewers applies 10 standardized criteria to news stories that include claims about health care interventions. ~2,000 reviews published.

Read More

News Release Reviews

We systematically evaluate the quality of health care-related news releases by journals, medical centers, drug/device makers, others.

Read More

Blog

Wide-ranging exploration of issues in journalism, journal publishing, health care PR, advertising and marketing. Some opinions - publisher Gary Schwitzer's & others'.

Read More